115 related articles for article (PubMed ID: 33771507)
1. GLP-1 reduces the migration of hepatocellular carcinoma cells via suppression of the stress-activated protein kinase/c-Jun N-terminal kinase pathway.
Yamada N; Matsushima-Nishiwaki R; Kobayashi K; Tachi J; Kozawa O
Arch Biochem Biophys; 2021 May; 703():108851. PubMed ID: 33771507
[TBL] [Abstract][Full Text] [Related]
2. Quercetin suppresses the migration of hepatocellular carcinoma cells stimulated by hepatocyte growth factor or transforming growth factor-α: Attenuation of AKT signaling pathway.
Yamada N; Matsushima-Nishiwaki R; Kozawa O
Arch Biochem Biophys; 2020 Mar; 682():108296. PubMed ID: 32032576
[TBL] [Abstract][Full Text] [Related]
3. Upregulation by duloxetine of the transforming growth factor-α-induced migration of hepatocellular carcinoma cells via enhancement of the c-Jun N-terminal kinase activity.
Matsushima-Nishiwaki R; Kamoi S; Kozawa O
Cell Biochem Funct; 2023 Oct; 41(7):814-822. PubMed ID: 37814477
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 22 (HSPB8) reduces the migration of hepatocellular carcinoma cells through the suppression of the phosphoinositide 3-kinase (PI3K)/AKT pathway.
Matsushima-Nishiwaki R; Toyoda H; Takamatsu R; Yasuda E; Okuda S; Maeda A; Kaneoka Y; Yoshimi N; Kumada T; Kozawa O
Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1629-1639. PubMed ID: 28456666
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylated Heat Shock Protein 20 (HSPB6) Regulates Transforming Growth Factor-α-Induced Migration and Invasion of Hepatocellular Carcinoma Cells.
Matsushima-Nishiwaki R; Toyoda H; Nagasawa T; Yasuda E; Chiba N; Okuda S; Maeda A; Kaneoka Y; Kumada T; Kozawa O
PLoS One; 2016; 11(4):e0151907. PubMed ID: 27046040
[TBL] [Abstract][Full Text] [Related]
6. Incretins Enhance PGF2α-Induced Synthesis of IL-6 and Osteoprotegerin in Osteoblasts.
Hioki T; Kuroyanagi G; Fujita K; Sakai G; Kawabata T; Kim W; Tachi J; Matsushima-Nishiwaki R; Iida H; Kozawa O; Tokuda H
Horm Metab Res; 2022 Jan; 54(1):42-49. PubMed ID: 34986499
[TBL] [Abstract][Full Text] [Related]
7. SERMs (selective estrogen receptor modulator), acting as estrogen receptor β agonists in hepatocellular carcinoma cells, inhibit the transforming growth factor-α-induced migration via specific inhibition of AKT signaling pathway.
Matsushima-Nishiwaki R; Yamada N; Hattori Y; Hosokawa Y; Tachi J; Hori T; Kozawa O
PLoS One; 2022; 17(1):e0262485. PubMed ID: 35007301
[TBL] [Abstract][Full Text] [Related]
8. Incretin accelerates platelet-derived growth factor-BB-induced osteoblast migration via protein kinase A: The upregulation of p38 MAP kinase.
Kawabata T; Tokuda H; Kuroyanagi G; Fujita K; Sakai G; Kim W; Matsushima-Nishiwaki R; Iida H; Yata KI; Wang S; Mizoguchi A; Otsuka T; Kozawa O
Sci Rep; 2020 Feb; 10(1):2341. PubMed ID: 32047216
[TBL] [Abstract][Full Text] [Related]
9. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
[TBL] [Abstract][Full Text] [Related]
10. c-jun amino-terminal kinase and mitogen activated protein kinase 1/2 mediate hepatocyte growth factor-induced migration of brain endothelial cells.
Rush S; Khan G; Bamisaiye A; Bidwell P; Leaver HA; Rizzo MT
Exp Cell Res; 2007 Jan; 313(1):121-32. PubMed ID: 17055484
[TBL] [Abstract][Full Text] [Related]
11. Suppression by heat shock protein 20 of hepatocellular carcinoma cell proliferation via inhibition of the mitogen-activated protein kinases and AKT pathways.
Matsushima-Nishiwaki R; Adachi S; Yoshioka T; Yasuda E; Yamagishi Y; Matsuura J; Muko M; Iwamura R; Noda T; Toyoda H; Kaneoka Y; Okano Y; Kumada T; Kozawa O
J Cell Biochem; 2011 Nov; 112(11):3430-9. PubMed ID: 21769911
[TBL] [Abstract][Full Text] [Related]
12. Olive oil polyphenols suppress the TGF-α-induced migration of hepatocellular carcinoma cells.
Yamada N; Matsushima-Nishiwaki R; Masue A; Taguchi K; Kozawa O
Biomed Rep; 2019 Jul; 1(1):1-5. PubMed ID: 31258902
[TBL] [Abstract][Full Text] [Related]
13. c-Jun N-terminal kinase inhibitor favors transforming growth factor-β to antagonize hepatitis B virus X protein-induced cell growth promotion in hepatocellular carcinoma.
Wu YH; Ai X; Liu FY; Liang HF; Zhang BX; Chen XP
Mol Med Rep; 2016 Feb; 13(2):1345-52. PubMed ID: 26648552
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte growth factor induction of collagenase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade.
Reboul P; Pelletier JP; Tardif G; Benderdour M; Ranger P; Bottaro DP; Martel-Pelletier J
Arthritis Rheum; 2001 Jan; 44(1):73-84. PubMed ID: 11212179
[TBL] [Abstract][Full Text] [Related]
15. P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.
Ching YP; Leong VY; Lee MF; Xu HT; Jin DY; Ng IO
Cancer Res; 2007 Apr; 67(8):3601-8. PubMed ID: 17440071
[TBL] [Abstract][Full Text] [Related]
16. HIPK2 regulates transforming growth factor-beta-induced c-Jun NH(2)-terminal kinase activation and apoptosis in human hepatoma cells.
Hofmann TG; Stollberg N; Schmitz ML; Will H
Cancer Res; 2003 Dec; 63(23):8271-7. PubMed ID: 14678985
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol Inhibits the Epidermal Growth Factor-Induced Migration of Osteoblasts: the Suppression of SAPK/JNK and Akt.
Kawabata T; Tokuda H; Fujita K; Kainuma S; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
Cell Physiol Biochem; 2017; 43(3):1025-1036. PubMed ID: 28968596
[TBL] [Abstract][Full Text] [Related]
18. c-Jun NH2-terminal kinase pathway is involved in constitutive matrix metalloproteinase-1 expression in a hepatocellular carcinoma-derived cell line.
Sugioka Y; Watanabe T; Inagaki Y; Kushida M; Niioka M; Endo H; Higashiyama R; Okazaki I
Int J Cancer; 2004 May; 109(6):867-74. PubMed ID: 15027120
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of pancreatic beta-cell replication by incretins involves transcriptional induction of cyclin D1 via multiple signalling pathways.
Friedrichsen BN; Neubauer N; Lee YC; Gram VK; Blume N; Petersen JS; Nielsen JH; Møldrup A
J Endocrinol; 2006 Mar; 188(3):481-92. PubMed ID: 16522728
[TBL] [Abstract][Full Text] [Related]
20. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
Xie YX; Liao R; Pan L; Du CY
Immunol Lett; 2017 Aug; 188():116-123. PubMed ID: 28668554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]